DFDA

Dimethyl Sulfoxide (DMSO)

Treatment for Interstitial Cystitis

Typical Dosage: 50mL of 50% solution intravesically

Effectiveness
65%
Safety Score
75%
Clinical Trials
5
Participants
2K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
50mL of 50% solution intravesically
Time to Effect
1-4 weeks
Treatment Duration
6-8 weeks induction, then maintenance
Evidence Quality
MODERATE
Confidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$6,800
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$11,353/QALY
QALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$12,363.64
Cost per Remission
$136,000
Dimethyl Sulfoxide (DMSO) Outcomes

for Interstitial Cystitis

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+55%
Remission Rate
+5%
Common Side Effects
Garlic-like body odor
+80%
Bladder discomfort
+40%
Bladder irritation
+15%

Sources:

nih.gov
researchgate.net
urotoday.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
2 completed trials for Dimethyl Sulfoxide (DMSO) in Interstitial Cystitis

Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC

NCT05223244COMPLETEDPHASE4
View Study
83 participants
INTERVENTIONAL
Started: Oct 1, 2011

Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A

NCT03103594COMPLETEDEARLY_PHASE1
View Study
2 participants
INTERVENTIONAL
Started: Aug 1, 2015